Sign up to get helpful information about RYSTIGGO

US-RZ-2400098

For adults with
GENERALIZED
MYASTHENIA
GRAVIS (gMG)

 

Discover what’s in reach with RYSTIGGO

Ask your doctor about the first FDA-approved treatment
for both anti-AChR and anti-MuSK antibody-positive gMG.

SEE RYSTIGGO RESULTS

AChR=acetylcholine receptor; MuSK=muscle-specific tyrosine kinase.

hero image
hero image
hero image
hero image

Reduces gMG symptoms

 

In a clinical trial, people taking RYSTIGGO saw significant improvements in activities of daily living as measured by MG-ADL.

Targeted gMG treatment

 

RYSTIGGO works by targeting FcRn, which can extend the life of harmful antibodies that can cause gMG.

Administered in minutes

 

Once prepared by a healthcare professional, RYSTIGGO subcutaneous infusions may be completed in about 15 minutes.

Individual results may vary, and not all people will experience improvements.
MG-ADL=Myasthenia Gravis Activities of Daily Living.
FcRn=Neonatal Fc receptor.
Infusion time may vary.

Reduces gMG symptoms

 

In a clinical trial, people taking RYSTIGGO saw significant improvements in activities of daily living as measured by MG-ADL.

Individual results may vary, and not all people will experience improvements.
MG-ADL=Myasthenia Gravis Activities of Daily Living.

Targeted gMG treatment

 

RYSTIGGO works by targeting FcRn, which can extend the life of harmful antibodies that can cause gMG.

FcRn=Neonatal Fc receptor.

Administered in minutes

 

Once prepared by a healthcare professional, RYSTIGGO subcutaneous infusions may be completed in about 15 minutes.

Infusion time may vary.
ONWARD™ personalized support designed to move you forward.

Here for you throughout your treatment

ONWARD™ provides personalized support, including help to understand coverage and financial options, tools to help you track symptoms, and guidance when starting and continuing treatment.

ONWARD is provided as a service of UCB and is intended to support the appropriate use of UCB medicines. ONWARD may be amended or canceled at any time without notice. Some program and eligibility restrictions may apply.